Abstract

Combination therapy has been extensively studied to achieve a more efficient inhibition of tumor progression. Herein, a nanoplatform based on layered double hydroxide (LDH) nanoparticles (NPs) is specifically constructed for the effective combination breast cancer therapy without the traditional anticancer drug. Cu‐containing LDH NPs loaded with indocyanine green (ICG) are devised with more Cu coordination defects (d‐Cu‐LDH/ICG) to induce photothermal/photodynamic/chemodynamic therapy (PTT/PDT/CDT) using only one laser source. The structurally created defects on the LDH surface and dual‐function ICG molecules in the LDH interlayer significantly enhance photothermal transduction and singlet‐oxygen (1O2) generation at 808 nm laser irradiation. Moreover, d‐Cu‐LDH/ICG NPs generate hydroxyl radicals (·OH) in the presence of H2O2 as Fenton catalysts, which are further enhanced by Cu(II) reduction with glutathione and temperature elevation. Consequently, d‐Cu‐LDH/ICG NPs significantly suppress 4T1 cell proliferation and show effective inhibition of the tumor growth in vivo through only one combined PTT/PDT/CDT under very mild laser irradiation, i.e., at 0.23 W cm−2 for 5 min with very low doses of Cu and ICG (2.5 and 0.5 mg kg−1). Altogether, the defect‐created d‐Cu‐LDH/ICG nanoplatform offers a new and safe treatment option for combination cancer therapy without using any anticancer drugs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.